0001104659-21-000339.txt : 20210104 0001104659-21-000339.hdr.sgml : 20210104 20210104163029 ACCESSION NUMBER: 0001104659-21-000339 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201230 FILED AS OF DATE: 20210104 DATE AS OF CHANGE: 20210104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Power Sean A CENTRAL INDEX KEY: 0001538845 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 21502153 MAIL ADDRESS: STREET 1: 787 SEVENTH AVENUE, 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 tm211514d1_4.xml OWNERSHIP DOCUMENT X0306 4 2020-12-30 0 0001001316 TG THERAPEUTICS, INC. TGTX 0001538845 Power Sean A 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 0 1 0 0 CFO, Secretary and Treasurer COMMON STOCK 2020-12-30 4 A 0 20000 0 A 653338 D Reflects a grant of restricted shares relating to 2020 service and performance. This award will vest in approximately equal tranches on January 1, 2022, 2023, 2024 and 2025. Includes shares of restricted Common Stock, which are subject to vesting. /s/ Sean A Power 2021-01-04